Johnson & Johnson’s single-dose COVID-19 vaccine candidate begins phase 3 trial

U.S. health officials insist the race for a vaccine isn’t cutting corners.

This entry was posted in Main. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *